tirzepatide hfpef trial At #ACC25, Dr. Milton Packer and colleagues present a new secondary analysis from the SUMMIT evaluating the effect of in patients with obesity, #HFpEF, and CKD. The trial demonstrated that # Impact of Body Mass Index,
Description
The vials are tiny, and often less than half full (if that!), and you might be thinking...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.
By taking these steps, Medicare beneficiaries can better understand their coverage options for tirzepatide and make informed decisions about their healthcare.

Wondering how semaglutide works for weight loss among non-diabetics
